₹ 3,344.00
5.80 (0.17%)
A
Ajanta Pharma
₹ 3,344.00
Ajanta Pharma EPS Summary (consolidated)
The latest quarterly EPS of Ajanta Pharma as of Q2 Sep 2026 stands at ₹31.07. This is a 16.15% growth quarter on quarter and 49.16% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹23.95. It beat the estimate by ₹7.12. For the FY2026 the EPS of Ajanta Pharma stands at ₹84.53. This is a 14.91% growth compared with FY2025.
Ajanta Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

